|
|
| Quarterly Results |
|
| Procter & Gamble Health Ltd | | Industry : Pharmaceuticals - Multinational | Chairman : S N Talwar | | Home : MNC Associate | Book Value: 485.4698795 | | BSE Code : 500126 | Market Cap: 7794.78 | | NSE Code : PGHL | P / E : 36.42 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 252.48 | 309.97 | 304.93 | 301.18 | | Other Income | 2.27 | 5.18 | 6.05 | 5.46 | | Total Income | 254.75 | 315.15 | 310.98 | 306.64 | | Total Expenditure | 185.04 | 208.32 | 216.27 | 255.84 | | Operating Profit | 69.71 | 106.83 | 94.71 | 50.80 | | Interest | 0.15 | 0.19 | 0.18 | 0.17 | | Gross Profit | 69.56 | 106.64 | 94.53 | 50.63 | | Depreciation | 6.84 | 6.92 | 6.48 | 6.50 | | Tax | 16.30 | 29.56 | 22.29 | 15.11 | | Deferred Tax | -0.14 | -1.91 | 0.19 | -0.80 | | Reported Profit After Tax | 46.56 | 72.07 | 65.57 | 29.82 |
|
|
|
|
|